Clinical Trials Browser

Phase 1 × Neuromyelitis Optica × Rituximab × Clear all

NCT00501748 2011-09-27

Safety and Tolerability of Rituximab in Neuromyelitis Optica

Phase 1 Completed

Myelitis, Transverse, Neuromyelitis Optica